Financial insights of CDNA

MyFinsight

For the year ending 2025-12-31, CDNA made $379,805K in revenue. -$21,354K in net income. Net profit margin of -5.62%.

Income Statement	2025-12-31	2024-12-31
Total revenue	379,805	333,785
Cost of testing services, product, patient and digital solutions	-	109,630
Cost of testing services, product, patient and digital solutions-Service	62,045	-
Litigation expense	-	-96,300
Cost of testing services, product, patient and digital solutions-Product	22,953	-
Restructuring costs	-	1,783
Cost of testing services, product, patient and digital solutions-Patient And Digital Solutions	38,241	-
Research and development	71,429	72,405
Sales and marketing	102,643	81,718
General and administrative	107,565	123,784
Litigation settlement expense	-5,710	-
Total operating expenses	410,586	293,020
(loss) income from operations	-30,781	40,765
Interest income, net	9,174	11,765
Other income, net	524	329
Total other income	9,698	12,094
(loss) income before income taxes	-21,083	52,859
Income tax expense	271	310
Net (loss) income	-21,354	52,549

Basic EPS	-0.4	1
Diluted EPS	-0.4	0.93
Basic Average Shares	53,287,546	52,773,247
Diluted Average Shares	53,287,546	56,620,590